Episode 228 -- April 2025 -- Part 2 AFP: American Family Physician

AFP: American Family Physician Podcast

American Academy of Family Physicians

Medicine, Americanfamilyphysician, Afppodcast, Familymedicinepodcast, Afp, Clinicalpodcast, Aafp, Health & Fitness, Primarycarepodcast, Medicinepodcast, Aafppodcast

2.4 • 649 Ratings

🗓️ 1 May 2025

⏱️ 17 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Buprenorphine for opioid use disorder (1:30), triptans for acute migraine (5:30), premenstrual syndrome (6:50), pain management for IUD insertion (11:00), liver fibrosis stage in chronic hepatitis C infection (12:30), and cold water immersion for muscle soreness (14:30).

Transcript

Click on a timestamp to play from that location

0:00.0	The AFP podcast is sponsored by the American Academy of Family Physicians, and by the Journal FPM.
0:09.0	FPM Journal provides you with simple yet powerful solutions to your everyday practice challenges, available in print and online.
0:17.4	Subscription information is available at aafp.org slash fpm.
0:22.5	Welcome to the American Family Physician Podcast for part two of the April 2025 issue. I'm Steve.
0:40.0	I'm Marion. And I'm Sierra. We are residents and faculty, mostly residents, from the University
0:45.2	of Arizona College of Medicine Phoenix Family Medicine residency. Today on the podcast, we're going
0:50.5	to talk about buprenorphine for opioid use disorder, triptans for acute migraine, premenstrual syndrome, pain management for IUD insertion, liver fibrosis stage, and chronic hepatitis C infection, and cold water immersion for muscle soreness.
1:06.6	The opinions expressed in the podcast are our own and do not represent the opinions with the American Academy of Family Physicians, the editor of American Family Physician or Banner Health.
1:13.3	Do not use this podcast for medical advice. Instead, see your own family doctor for medical care.
1:19.8	We're on a mission to live in the best from American feminization. All right.
1:30.3	All right.
1:34.3	We're going to start with common questions about buprenorphine treatment for opioid use disorder.
1:40.0	This is from Dr. Teamstra from Wisconsin.
1:43.2	Opioid agonist medications are the most effective treatments for moderate or severe opioid use disorder.
1:49.6	Methadone, a full opioid agonist, is only distributed by regulated specialty clinics.
1:55.2	Pupinorphine is a mixed agonist antagonist and can be prescribed by all family physicians with Schedule 3 authority.
2:03.4	Both treatments lower patient mortality rates by more than 50 percent, and they have similar
2:08.4	retention rates and efficacy. Compared to methadone, buprenorphine has been shown to have a lower
2:13.3	risk of misuse, cardiac arrest, and death. The United States Preventative Services Task Force recommends screening all adults for unhealthy
2:21.0	drug use if services are available.
2:23.6	The U.S. Food and Drug Administration has approved buprenorphine and the combination of buprenorphine
2:29.3	naloxone for use in patients 16 years and older.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from American Academy of Family Physicians, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of American Academy of Family Physicians and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.